Cancer Progress and Priorities: Uterine Cancer - PubMed
Cancer Progress and Priorities: Uterine Cancer
Ashley S Felix et al. Cancer Epidemiol Biomarkers Prev. 2018 Sep.
No abstract available
Conflict of interest statement
Conflict of interest: The authors have nothing to disclose.
Figures
![Figure 1 –](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16fe/6504985/3d3b9f8f7549/nihms-1014194-f0001.gif)
Age-standardized incidence rates for corpus uteri cancer, GLOBOCAN, 2012 shows the age-standardized incidence rates for corpus uteri cancer using data from GLOBOCAN 2012.
![Figure 2 –](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16fe/6504985/ea8872bcee52/nihms-1014194-f0002.gif)
Age-specific uterine cancer incidence rates by race among U.S. women, SEER-18, 2003–2014 shows age-specific uterine cancer incidence rates among non-Hispanic White, Hispanic White, Black, American Indian/Alaskan Native, and Asian/Pacific Islander U.S. women using data from the SEER Program.
![Figure 3 –](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16fe/6504985/2667c0ee5e6a/nihms-1014194-f0003.gif)
Trends in uterine cancer incidence and mortality among U.S. women, SEER-9, 1973–2014 shows uterine cancer incidence among White and Black U.S. women using data from the SEER Program.
![Figure 4 –](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16fe/6504985/1f2de709fbb9/nihms-1014194-f0004.gif)
Age-standardized mortality rates for corpus uteri cancer, GLOBOCAN, 2012 shows the age-standardized mortality rates for corpus uteri cancer using data from GLOBOCAN 2012.
![Figure 5 –](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16fe/6504985/153d58da365a/nihms-1014194-f0005.gif)
Summary of the magnitude of association for established endometrial cancer risk factors summarizes the magnitude of associations for established endometrial cancer risk factors. Risks are approximate and can vary depending on the extent of exposure.
Similar articles
-
[Risk factors in malignant forms of gestational trophoblastic disease].
Rob L, Zavadil M, Vlachová J, Schusterová H. Rob L, et al. Cesk Gynekol. 1993 Jun;58(3):134-8. Cesk Gynekol. 1993. PMID: 8394221 Czech. No abstract available.
-
Kinutani M, Nagai N, Kurihara K, Sakata K, Tanimoto H, Murakami T, Takehara K, Takenaka M, Okamoto E, Ohama K. Kinutani M, et al. Nihon Sanka Fujinka Gakkai Zasshi. 1994 Sep;46(9):911-4. Nihon Sanka Fujinka Gakkai Zasshi. 1994. PMID: 7963892 Japanese. No abstract available.
-
[Hydatidiform mole--current knowledge].
Pekhlivanov B, Piperkov T. Pekhlivanov B, et al. Akush Ginekol (Sofiia). 1990;29(2):62-6. Akush Ginekol (Sofiia). 1990. PMID: 2205119 Review. Bulgarian. No abstract available.
-
[Development of a uterine sarcoma 18 years after radiotherapy for carcinoma of the uterine cervix].
Eimer H, Rauskolb R. Eimer H, et al. Geburtshilfe Frauenheilkd. 1972 Dec;32(12):1034-7. Geburtshilfe Frauenheilkd. 1972. PMID: 4649406 German. No abstract available.
-
Marfunin DL. Marfunin DL. Akush Ginekol (Mosk). 1988 Nov;(11):6-9. Akush Ginekol (Mosk). 1988. PMID: 3071164 Review. Russian. No abstract available.
Cited by
-
Levine MD, Pearlman R, Hampel H, Cosgrove C, Cohn D, Chassen A, Suarez A, Barrington DA, McElroy JP, Waggoner S, Nakayama J, Billingsley C, Resnick K, Andrews S, Singh S, Jenison E, Clements A, Neff R, Goodfellow PJ; Ohio Prevention and Treatment of Endometrial Cancer Initiative Study Group. Levine MD, et al. JCO Precis Oncol. 2021 Nov;5:1588-1602. doi: 10.1200/PO.21.00249. JCO Precis Oncol. 2021. PMID: 34994648 Free PMC article.
-
Characterizing the extracellular matrix transcriptome of cervical, endometrial, and uterine cancers.
Cook CJ, Miller AE, Barker TH, Di Y, Fogg KC. Cook CJ, et al. Matrix Biol Plus. 2022 Jul 16;15:100117. doi: 10.1016/j.mbplus.2022.100117. eCollection 2022 Aug. Matrix Biol Plus. 2022. PMID: 35898192 Free PMC article.
-
Risk of Endometrial Cancer in Women with Diabetes: A Population-Based Retrospective Cohort Study.
Zabuliene L, Kaceniene A, Steponaviciene L, Linkeviciute-Ulinskiene D, Stukas R, Arlauskas R, Vanseviciute-Petkeviciene R, Smailyte G. Zabuliene L, et al. J Clin Med. 2021 Aug 4;10(16):3453. doi: 10.3390/jcm10163453. J Clin Med. 2021. PMID: 34441749 Free PMC article.
-
Tie-2, G-CSF, and Leptin as Promising Diagnostic Biomarkers for Endometrial Cancer: A Pilot Study.
Roškar L, Klančič T, Knific T, Rižner TL, Smrkolj Š. Roškar L, et al. J Clin Med. 2021 Feb 15;10(4):765. doi: 10.3390/jcm10040765. J Clin Med. 2021. PMID: 33671851 Free PMC article.
-
Cathey AL, Nguyen VK, Colacino JA, Woodruff TJ, Reynolds P, Aung MT. Cathey AL, et al. J Expo Sci Environ Epidemiol. 2023 Sep;33(5):687-698. doi: 10.1038/s41370-023-00601-6. Epub 2023 Sep 18. J Expo Sci Environ Epidemiol. 2023. PMID: 37718377 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. [
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: a cancer journal for clinicians. 2018;68(1):7–30. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA: a cancer journal for clinicians. 2017;67(1):7–30. - PubMed
-
- Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in Women: Burden and Trends. Cancer Epidemiol Biomarkers Prev. 2017;26(4):444–57. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical